White label ELPA - ClinicalTrials.eu

Comparing tacrolimus and mycophenolate mofetil bioequivalence in kidney transplant recipients taking immunosuppressive medications

Not recruiting

3 1 1 1
Investigated Diseases:
- Renal transplant
Investigated Drugs:
- Mycophenolate Mofetil
- Tacrolimus
Study to evaluate gadopiclenol-enhanced magnetic resonance imaging for diagnosis in patients with breast cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer female
Study of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson’s disease and motor fluctuations

Not recruiting

3 1 1 1
Investigated Drugs:
- Benserazide Hydrochloride
- Levodopa
Study of lavender oil (Silexan) in patients with mild to moderate major depressive disorder comparing its effectiveness to placebo

Not recruiting

3 1
Investigated Drugs:
- Lavender Oil
Comparing liquid versus capsule forms of phosphatidylcholine in patients with alcoholic liver disease, chronic hepatitis B, and metabolic liver disease

Not recruiting

3 1 1
Study of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment

Not recruiting

2 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- (2S)-2-CYCLOPENTYL-2-[(5S)-2-[(2R,3R)-3-CYCLOPROPYL-1-METHYLAZIRIDINE-2-CARBONYL]-2,7-DIAZASPIRO[4.4]NONAN-7-YL]-N-[(6S,8S,14S)-21-[5-(4-CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-METHOXYETHYL]PYRIDIN-3-YL]-18,18-DIMETHYL-9,15-DIOXO-22-(2,2,2-TRIFLUOROETHYL)-5,16-DIOXA-2,10,22,28-TETRAZAPENTACYCLO[18.5.2.12,6.110,14.023,27]NONACOSA-1(26),20,23(27),24-TETRAEN-8-YL]ACETAMIDE
+3
Study of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema

Not recruiting

3 1
Investigated Diseases:
- Hereditary angioedema with C1 esterase inhibitor deficiency
- Hereditary angioedema
Investigated Drugs:
- NAVENIBART
+5
Study of 20-valent pneumococcal conjugate vaccine (PCV20) booster response in healthy adults aged 78-84 years

Not recruiting

3 1 1 1
Investigated Drugs:
Study of radiotherapy with durvalumab and ceralasertib in patients with stage III non-small cell lung cancer who have thoracic relapse after PACIFIC treatment

Not recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer stage III
Investigated Drugs:
- Ceralasertib
- Durvalumab
Study of ritlecitinib for treating severe alopecia areata in children aged 6 to under 12 years

Not recruiting

3 1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies